Balzarini, J., et al., "Potent and Selective Anti-HTLV-III/LAV Activity of 2',3'-Dideoxycytidinene the 2',3'-Unsaturated Derivative of 2',3'-Dideoxycytidine," Biochemical and Biophysical Research Communications, vol. 140, No. 2, pp. 735-742 (1986). |
Belleau, B., et al., "Design and Activity of a Novel Class of Nucleotide Analogs Effective Against HIV-1," 5th International Conference on AIDS, Montreal, Quebec, Canada, Jun. 4-9, 1989. |
Carter, et al., "Activities of (-)-Carbovir and 3'-Azido-3'-Deoxythymidine Against Human Immunodeficiency Virus in Vitro," Antimicrobial Agents and Chemotherapy, vol. 34, No. 6, pp. 1297-1300 (1990). |
Chang, Chien-Neng et al., "Deoxycytidine Deaminase-resistant Steroisomer Is the Active Form of (+)-2',3'-Dideoxy-3'-thiacytidine in the Inhibition of Hepatitis B Virus Replication," The Journal of Biological Chemistry, vol. 357, No. 20, pp. 13938-13942. |
Chu, et al., "Structure-Activity Relationships of Pyrimidine Nucleosides as Antiviral Agents for Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells," J. Med. Chem. vol. 32, p. 612 (1989). |
Chu, et al., "Comparative Activity of 2',3'-Saturated and Unsaturated Pyrimidine and Purine Nucleosides Against Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells," Biochem. Pharm., vol. 37, No. 19, pp. 3543-3548 (1988). |
Chu, C.K., et al., "An Efficient Total Synthesis of 3'-Azido-3'-Deoxythiymidine (AZT) and 3'-Azido-2',3'-Dideoxyuridine (AZDDU, CS-87) from D-Mannitol," Tetrahedron Lett. 1988, 5349. |
Cretton, E., et al., "Pharmokinetics of 3'-Azido-3'-Dexoythymidine and its Catabolites and Interactions with Probenecid in Rhesus Monkeys," Antimicrobial Agents and Chemotherapy, pp. 801-807 (1991). |
Furman, et al., "The Anti-Hepatitis B Virus Activities, Cytotoxicities, and Anabolic Profiles of the (-) and (+) Enantiomers of cis-5-Fluoro-1-�2-(Hydromethyl)-1,3-Oxthiolane-5-yl!Cytosine," Antimicrobial Agents and Chemotherapy, vol. 36, No. 12, pp. 2686-2692. |
Jeong, L., et al., "Asymmetric Synthesis and Biological Evaluation of .beta.-L-(2R,5S)-and .alpha.-L-(2R-5R)-1,3-Oxathiolane-Pyrimidine and -Purine Nucleosides and Potential Anti-HIV Agents," J. Med. Chem. vol. 36 (1993). |
Lin, et al., "Potent and Selective In Vitro Activity of 3'-Deoxythmindine-2-Ene-(3'-Deoxy-2',3'-Didehydrothymidine) Against Human Immunodeficiency Virus," Biochem. Pharm. vol. 36, No. 17, p. 2716 (1987). |
Mitsuya, H., et al., "Rapid in Vitro Systems for Assessing Activity of Agents Against HTLV-III/LAV," AIDS: Modern Concepts and Therapeutic Challenges, S. Broder, Ed. (Marcel-Dekker, New York, 1987), p. 303. |
Mitsuya, J., et al., 3'-Azido-3'-Deoxythymidine (BW A 509U): An Antiviral Agent that Inhibitis the Infectivity and Cytopathic Effect of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus In Vitro, Proc. Natl. Acad. Sci., USA, vol. 82, pp. 7097-7100 (1985). |
Norbeck, D., et al., "A New 2',3'-Dideoxynucleoside Prototype with In Vitro Activity Against HIV," Tetrahedron Lett. 1989, 6263. |
Okabe, M., et al., "Synthesis of the Dideoxynucleosides ddC and CNT from Glutamic Acid, Ribonolactone, and Pyrimidine Bases," J. Org. Chem. 1989. |
Richman, D. D., et al., "The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex," N. Eng. J. Med. 1987, 317:192. |
Satsumabayashi, S. et al., "The Synthesis of 1,3-Oxathiolane-5-one Derivatives," Bull. Chem. Soc. Japan, 1972, 45:913. |
Schinazi, R.F., et al., "Activities of the Four Optical Isomers of 2',3'-Dideoxy-3'-Thiacytidine (BCH-189) against Human Immunodeficiency Virus Type 1 in Human Lymphocytes," Antimicrobial Agents and Chemotherapy 36(3) 672-676 (1992). |
Schinazi, R.F., et al., "Insights nito HIV Chemotherapy," AIDS Research and Human Retroviruses 8(6) (1992) 963-990. |
Schinazi, R.F., et al., "Pharmacokinetics and Metabolism of Racemic 2',3'-Dideoxy-5-Fluoro-3'-Thiacytidine in Rhesus Monkeys," Antimicrobial Agents and Chemotherapy 36(11) 2432-2438 (1992). |
Schinazi, R.F., et al., "Selective Inhibition of Human Immunodeficiency Viruses by Racemates and Enantiomers of cis-5-Fluoro-1-�2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl!Cytosine," Antimicrobial Agents and Chemotherapy 36(11) 2423-2431 (1992. |
Schinazi, R.F., et al., "Substrate Specificity of Escherichia coli Thymidine Phosphorylase for Pyrimidine Nucleoside with an Anti-Human Immunodeficiency Virus Activity," Biochemical Pharmacology 44(2) (1992) 199-204. |
Storer, Richard, et al., "The Resolution and Absolute Stereochemistry of the Enantiomers of cis-1-�2-Hydroxymethyl)-1,3-Oxathiolan-5-yl)Cytosine(BCH189): Equipotent Anti-HIV Agents," Nucleosides &Nucleotides, 12(2), 225-236 (1993). |
Vorbruggen et al, "Nucleoside Synthesis with Trimethylsilyl Triflate and Perchlorate as Catalysts," Chem. Ber. 1981, 114:1234-1255. |
Wilson, L.J., et al. "A General Method for Controlling Glycosylation Stereochemistry in the Synthesis of 2'-Deoxyribose Nucleosides," Tetrahedron Lett. 1990, 1815. |
Zhu, Zhou, et al., "Cellular Metabolism of 3'-Azido-2',3'-Dideoxyuridine with Formation of 5'-O-Diphophoshexase Derivatives by Previously Unrecognized Metabolic Pathways of 2'-Deoxyuridine Analogs," Molecular Pharmacology, vol. 38, pp. 929-938. |
Saari et al, J. Med. Chem. 1992, 35, 3792-3802. |
Gerlt, Chem. Abst. 107:14979 (1987). |
Boutelje et al, Chem Abst 108:128048 (1987). |
Norin, Chem Abst 108:146380 (1987). |
Ohno et al. Chem Abst 112:194612 (1989). |
Belleau et al, 112CA:198359W 1990. |
Kim, H.O., et al., "L-.beta.-(2S,4S)-and L-.alpha.-(2S-4R)-Dioxolanyl Nucleosides as Potential Anti-HIV Agents: Asymmetric Synthesis and Structure-Activity Relationships," J. Med. Chem., 1993, 36, 519-528. |
Kim, H.O., et al., "1,3-Dioxolanylpurine Nucelosides (2R,4R) and (2R,4S) with Selective Anti-HIV-1 Activity in Human Lymphocytes," J. Med. Chem. 1993, 36, 30-37. |
Wilson, L.J., et al., "The Synthesis and Anti-HIV Activity of Pyrimidine Dioxolanyl Nucleosides," Bioorganic & Medicinal Chemistry Letters, 1993, 3, 169-174. |